No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Times cited: 2
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
Times cited: 6
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
Breast cancer research : BCR.
Times cited: 13
- Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. The British journal of surgery. 2014 Academic Article GET IT